Skip to main content
. 2023 Jul 4;136(13):jcs261026. doi: 10.1242/jcs.261026

Fig. 6.

Fig. 6.

Complexin participates in cAMP-evoked full fusions and neuropeptide release. (A) Release indicated by loss of ANF–GFP fluorescence (F) is induced by a 1 min 70 Hz stimulation (indicated by the horizontal bar) in elav-GAL4 UAS-ANF-GFP;;UAS-CpxS126A, CpxSH1 animals. n=4 NMJs (one bouton each per animal). (B) Forskolin-evoked ANF–GFP release in 7 min is abolished in elav-GAL4 UAS-ANF-GFP;;UAS-CpxS126A, CpxSH1 animals. WT, wild type Cpx; PB Con, photobleaching control. n=4–6 NMJs (1 bouton each per animal). ****P<0.0001; ns, not significant (one-way ANOVA followed by Tukey's test). (C) Frequency of kiss-and-run (KR, black columns) and full fusions (FF, white columns) in boutons from elav-GAL4;UAS-Dilp2-FAP;UAS-CpxS126A, CpxSH1/CpxDelta2 flies in the absence and presence of forskolin (−FSK: n=7 NMJs, 53 boutons, four animals; +FSK: n=14 NMJs, 124 boutons, six animals). CpxSH1 and CpxDelta2 are null mutants. Note that forskolin does not have a statistically significant effect (ns, not significant by unpaired two-tailed t-test) on full fusion frequency (open bars). Likewise, no effect was produced on kiss-and-run frequency. 1/min, min−1.